MedTrace Logo

Establishment and Clinical Application of Risk Classification Model Based on Molecular Typing of Medulloblastoma in Children

NCT05406947 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2023-02-08

No results posted yet for this study

Summary

The purpose of this study:(1) Development of a new risk classification model for childhood medulloblastoma. (2) Evaluation and improvement of existing individualized treatment protocols.

Conditions

  • Medulloblastoma, Childhood

Interventions

OTHER

Prospective observational study, no intervention

Prospective observational study, no intervention

Sponsors & Collaborators

  • Beijing Neurosurgical Institute

    collaborator OTHER

  • Beijing Children's Hospital

    collaborator OTHER

  • Beijing Shijitan Hospital, Capital Medical University

    collaborator OTHER

  • Xuanwu Hospital, Beijing

    collaborator OTHER

  • Peking University Third Hospital

    collaborator OTHER

  • Beijing Tiantan Hospital

    lead OTHER

Principal Investigators

  • Yongji Tian, MD · Beijing TianTanHospital, China Capital Medical University

  • FU ZHAO, MD · Beijing Neurosurgical Institute

Eligibility

Min Age
6 Months
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-30
Primary Completion
2028-12-31
Completion
2030-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05406947 on ClinicalTrials.gov